Polypharmacy, defined as the concurrent use of five or more medications, is a growing public health concern in Pakistan, particularly among the elderly and those with multiple chronic conditions. The prevalence of polypharmacy is alarmingly high, with studies indicating rates between 20% to 50% in various healthcare settings. Contributing factors include the rising burden of non-communicable diseases, a lack of standardized prescribing practices, and inadequate regulation of the pharmaceutical industry. The consequences of polypharmacy are severe, leading to increased adverse drug reactions, drug-drug interactions, non-adherence, and higher healthcare costs. Addressing this issue requires a multi-faceted approach: promoting rational prescribing practices, improving care coordination, educating patients and caregivers, and strengthening pharmaceutical regulations. A comprehensive strategy is crucial for enhancing health outcomes and improving the quality of life for patients in Pakistan.

Pakistan, Polypharmacy, Elderly, Self-medication, Healthcare, Education.

The rising prevalence of polypharmacy is linked to a myriad of factors, including the growing burden of non-communicable diseases (NCDs), inadequate prescribing practices, and insufficient regulation of the pharmaceutical sector. This article aims to provide a comprehensive overview of the problem of polypharmacy in Pakistan, its implications, and potential strategies for addressing this critical issue. Recent studies reveal a concerning trend in the prevalence of polypharmacy in Pakistan. Research conducted in various healthcare settings shows that the prevalence ranges is quite higher among older adults.[1,2] A notable study in Karachi found that a significant proportion of elderly patients were taking five or more medications concurrently.[2] This phenomenon is not limited to urban centers; it is also prevalent in rural areas, where limited access to healthcare services exacerbates the issue.[3]

Pakistan is facing a significant increase in the burden of NCDs, such as diabetes, hypertension, and cardiovascular diseases. According to the World Health Organization (WHO), NCDs account for approximately 58% of all deaths in the country.[4] Many elderly patients suffer from multiple chronic conditions that necessitate complex medication regimens, leading to polypharmacy as physicians prescribe various medications to manage these health issues. The prescribing practices in Pakistan are often inconsistent and poorly regulated. There is a lack of standardized protocols for medication prescribing, particularly in primary healthcare settings. Physicians may prescribe medications based on personal experience or patient requests, rather than adhering to clinical guidelines.[5] This absence of rational prescribing contributes significantly to the occurrence of polypharmacy.

The pharmaceutical landscape in Pakistan is characterized by many drug manufacturers and a lack of stringent regulation. Many medications are available over the counter, promoting a culture of self-medication, particularly in rural areas where healthcare professionals are less accessible.[6,7] The widespread availability of drugs without prescriptions leads to patients combining multiple therapies without adequate medical supervision.

The implications of polypharmacy are multifaceted and detrimental to patient health and safety:

• Polypharmacy significantly increases the risk of adverse drug reactions (ADRs), especially in elderly patients whose bodies may metabolize drugs differently due to age-related physiological changes. Studies have shown that ADRs are a leading cause of hospitalization in Pakistan, with polypharmacy identified as a major risk factor.[8]
• The risk of drug-drug interactions escalates with polypharmacy. These interactions can diminish the effectiveness of treatments and lead to new health complications. For instance, combining certain antihypertensive drugs with nonsteroidal anti-inflammatory drugs (NSAIDs) can cause renal impairment.[9]
• Managing multiple medications can be overwhelming for patients, particularly the elderly. This complexity often results in poor adherence to prescribed regimens, which can lead to suboptimal management of chronic conditions.[10] Moreover, the likelihood of medication errors increases when patients or caregivers struggle to navigate complex drug regimens.

Polypharmacy not only affects patient health but also leads to increased healthcare costs. The financial burden associated with treating ADRs, managing drug interactions, and hospitalizations due to medication-related complications places significant strain on the healthcare system.[11]

Mitigating the issue of polypharmacy in Pakistan requires a multifaceted approach involving healthcare professionals, policymakers, and the pharmaceutical industry:

• Healthcare professionals should be encouraged to adhere to evidence-based guidelines when prescribing medications. Developing national prescribing protocols and employing clinical decision-support tools can help standardize practices and minimize unnecessary prescriptions.[12]
• Improved communication and coordination among healthcare providers are essential for effective medication management. Implementing electronic health records (EHRs) can facilitate better information sharing and reduce the risks associated with polypharmacy.[13]
• Raising awareness among patients and caregivers about the importance of adhering to prescribed medications and the danger of self-medication is crucial. Public health campaigns can educate communities about safe medication practices and the risks associated with polypharmacy.[14]
• Stricter regulations on the sale of medications can help curb self-medication and inappropriate drug use. Ensuring that prescription drugs are only available through licensed healthcare providers can reduce the incidence of polypharmacy driven by unregulated access to medications.[15]
• Polypharmacy represents a growing public health challenge in Pakistan, driven by the increasing burden of chronic diseases, inadequate prescribing practices, and insufficient regulation of the pharmaceutical industry. The resulting consequences, ranging from adverse drug reactions to increased healthcare costs, underscore the urgent need for a coordinated response.

By promoting rational prescribing, improving care coordination, educating patients, and enhancing pharmaceutical regulations, Pakistan can effectively address the issue of polypharmacy and improve health outcomes for its population.

Not reported

Not reported

Asim Abid Minhas
Department of Medicine
Dow Medical College, Karachi, Pakistan
Email: asimabidminhas@outlook.com

The author contributed to the conceptualization, investigation, and data curation by acquiring and critically reviewing the selected articles and was involved in the writing – original draft preparation and writing – review and editing to refine the manuscript.

None

Not reported

None

https://doi.org/10.63096/medtigo3061117

Asim AM. The growing problem of polypharmacy in Pakistan: an urgent need for intervention. medtigo J Pharmacol. 2024;1(1):e3061117. doi:10.63096/medtigo3061117 Crossref